Kawasaki disease (KD), an acute, self-limiting, medium-sized arterial vasculitis, is now the most common cause of acquired heart disease in childhood in the developed world. In this review, we discuss the diagnosis of KD, predicting resistance to traditional therapy and treatment options in refractory or high-risk disease. We also highlight ongoing clinical trials and other potential avenues of research which may prove beneficial in managing children, especially those with resistant KD. Copyright © 2019 Duignan et al.
CITATION STYLE
Duignan, S., Doyle, S. L., & McMahon, C. J. (2019). Refractory Kawasaki disease: diagnostic and management challenges. Pediatric Health, Medicine and Therapeutics, Volume 10, 131–139. https://doi.org/10.2147/phmt.s165935
Mendeley helps you to discover research relevant for your work.